CP
CenterBook Partners Portfolio holdings
AUM
$1.8B
This Quarter Return
+3.71%
1 Year Return
+10.58%
3 Year Return
+36.94%
5 Year Return
–
10 Year Return
–
AUM
$1.63B
AUM Growth
+$1.63B
(+1.1%)
Cap. Flow
-$72.2M
Cap. Flow
% of AUM
-4.44%
Top 10 Holdings %
Top 10 Hldgs %
16.75%
Holding
550
New
162
Increased
86
Reduced
193
Closed
109
Top Buys
| 1 |
Costco
COST
|
$27.9M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$27.3M |
| 3 |
Microsoft
MSFT
|
$21.2M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$20.2M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$20M |
Top Sells
| 1 |
JD.com
JD
|
$13.4M |
| 2 |
GE Vernova
GEV
|
$12.3M |
| 3 |
WEX
WEX
|
$11M |
| 4 |
argenx
ARGX
|
$10.6M |
| 5 |
BioNTech
BNTX
|
$10.3M |
Sector Composition
| 1 | Technology | 27.72% |
| 2 | Healthcare | 14.73% |
| 3 | Consumer Discretionary | 10.43% |
| 4 | Communication Services | 8.79% |
| 5 | Consumer Staples | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
US Physical Therapy
USPH
$1.26B
| $6.59M | 0.4% | 77,813 +71,513 | +1,135% | +$6.05M |
|
|
AMPS
77
DELISTED
Altus Power, Inc.
AMPS
| $6.57M | 0.4% | 2,066,732 +388,793 | +23% | +$1.24M |
|
78
Nordic American Tanker
NAT
$659M
| $6.48M | 0.4% | 1,766,106 +289,100 | +20% | +$1.06M |
|
79
Colgate-Palmolive
CL
$67.9B
| $6.43M | 0.4% | +61,945 | New | +$6.43M |
|
80
Arhaus
ARHS
$1.65B
| $6.33M | 0.39% | 514,388 +258,565 | +101% | +$3.18M |
|
81
Royalty Pharma
RPRX
$15.6B
| $6.17M | 0.38% | +218,260 | New | +$6.17M |
|
82
Insmed
INSM
$28.8B
| $5.94M | 0.37% | +81,336 | New | +$5.94M |
|
83
Biogen
BIIB
$19.4B
| $5.81M | 0.36% | 29,987 -26,841 | -47% | -$5.2M |
|
84
Procore
PCOR
$10.4B
| $5.7M | 0.35% | +92,306 | New | +$5.7M |
|
85
CarGurus
CARG
$3.43B
| $5.46M | 0.34% | 181,776 -50,767 | -22% | -$1.52M |
|
86
Indivior
INDV
$3.03B
| $5.45M | 0.33% | +558,683 | New | +$5.45M |
|
87
Marvell Technology
MRVL
$54.2B
| $5.44M | 0.33% | 75,455 -38,849 | -34% | -$2.8M |
|
|
DX
88
Dynex Capital
DX
$1.64B
| $5.44M | 0.33% | 426,402 +81,159 | +24% | +$1.04M |
|
89
Expedia Group
EXPE
$26.6B
| $5.43M | 0.33% | 36,688 -54,128 | -60% | -$8.01M |
|
90
JFrog
FROG
$5.76B
| $5.43M | 0.33% | 186,825 +31,107 | +20% | +$903K |
|
91
AGCO
AGCO
$8.07B
| $5.41M | 0.33% | 55,292 -10,594 | -16% | -$1.04M |
|
|
DNB
92
DELISTED
Dun & Bradstreet
DNB
| $5.33M | 0.33% | 463,309 -42,801 | -8% | -$493K |
|
93
Esperion Therapeutics
ESPR
$448M
| $5.14M | 0.32% | 3,112,585 +1,543,126 | +98% | +$2.55M |
|
94
Ligand Pharmaceuticals
LGND
$3.15B
| $5.1M | 0.31% | 50,976 -2,403 | -5% | -$241K |
|
95
Chemours
CC
$2.31B
| $5.06M | 0.31% | +249,207 | New | +$5.06M |
|
96
indie Semiconductor
INDI
$899M
| $5.06M | 0.31% | 1,268,690 +693,921 | +121% | +$2.77M |
|
97
Toronto Dominion Bank
TD
$128B
| $5.03M | 0.31% | 79,495 -103,937 | -57% | -$6.58M |
|
98
Oracle
ORCL
$635B
| $5M | 0.31% | +29,354 | New | +$5M |
|
99
Cullinan Oncology
CGEM
$445M
| $5M | 0.31% | 298,666 -42,596 | -12% | -$713K |
|
100
Kyndryl
KD
$7.35B
| $4.96M | 0.3% | 215,657 -41,451 | -16% | -$953K |
|